Drugs / Fruitflow-II
last change Feb 2016 re-read 9 days ago

Fruitflow-II

Developed for
amnestic disorder

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
— NCT01766180 Comparator Jan 2013 → Jan 2016 amnestic disorder Neurolgy Institute for Brain Health and Fitness Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Fruitflow-II ClinicalTrials.gov intervention name — accepted as the source's own label NCT01766180 ↗
Action Inhibit “have been shown to inhibit glycoprotein IIb/IIIa” NCT01766180 ↗
Route Oral “150 mg/day for 3 months, orally” NCT01766180 ↗